Edesa Biotech (NASDAQ:EDSA) Shares Down 0.4% - Should You Sell?Market Beat·Jul 23 at 11:40 PMEDSA-5.70%STT-1.80%
Top Biotech Gainers: BOLD Begins Anew, MNPR NDA Filing On Track, GALT Soars On FDA Alignmentrttnews·Jun 23 at 10:15 PMGALT-2.96%EDSA-5.70%
Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors | EDSA Stock NewsStockTitan·Jun 11 at 12:15 AMEDSA-5.70%
Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury | EDSA Stock NewsStockTitan·Jun 5 at 12:20 AMEDSA-5.70%
MTVA Gains Weight, CODX Takes A Shot At Ebola, EDSA To Reveal New Data, BDTX On Watchrttnews·May 20 at 04:04 AMADIL+3.20%BDTX-0.87%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·May 19 at 12:06 PMAMIX-0.90%WOK-4.21%
Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference | EDSA Stock NewsStockTitan·May 19 at 12:15 AMEDSA-5.70%BIB+0.30%
